Crinetics Pharmaceuticals, Inc. — Form D

Crinetics Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-02-23. The offering totals $65.0M, of which $60.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
Mason Scott Freeman, M.D.DirectorSan Diego, CA
Matthew K FustDirectorMenlo Park, CA
Steve Scott Kaldor, Ph.DDirectorSan Diego, CA
Weston K Nichols, Ph.DDirectorSan Diego, CA
Jack B NielsenDirectorAustin, TX
Richard Scott Struthers, Ph.DDirectorSan Diego, CA
Wendell Scott Wierenga, Ph.DDirectorSan Diego, CA
Richard Scott Struthers, Ph.DExecutive OfficerSan Diego, CA
JAMES VIVALDI HASSARDExecutive OfficerSAN DIEGO, CA
STEPHEN VIVALDI BETZExecutive OfficerSAN DIEGO, CA
ROGERIO VIVALDI COELHO, M.D.DirectorSAN DIEGO, CA
WESTON SCOTT NICHOLS, PhDDirectorSAN DIEGO, CA
MARC SCOTT WILSONExecutive OfficerSAN DIEGO, CA
CAMILLE SCOTT BEDROSIAN, M.D.DirectorSAN DIEGO, CA
MATTHEW SCOTT FUSTDirectorSAN DIEGO, CA
RICHARD SCOTT STRUTHERS, PhDDirectorSAN DIEGO, CA
RICHARD SCOTT STRUTHERS, PhDExecutive OfficerSAN DIEGO, CA
JEFF VIVALDI KNIGHTExecutive OfficerSAN DIEGO, CA
WENDELL SCOTT WIERENGA, PhDDirectorSAN DIEGO, CA
DANA VIVALDI PIZZUTIExecutive OfficerSAN DIEGO, CA
CAREN SCOTT DEARDORFDirectorSAN DIEGO, CA
STEPHANIE SCOTT OKEYDirectorSAN DIEGO, CA
YunFei F ZhuExecutive OfficerSan Diego, CA
Steve Scott KaldorDirectorSan Diego, CA
Mason Scott FreemanDirectorSan Diego, CA

Other filings by this issuer (2)

FiledFormOfferingSold
2024-03-11D$350.0M$350.0M
2015-11-16D$40.0M$18.0M

More